442 related articles for article (PubMed ID: 2548710)
21. Protein-linked DNA strand breaks induced in mammalian cells by camptothecin, an inhibitor of topoisomerase I.
Covey JM; Jaxel C; Kohn KW; Pommier Y
Cancer Res; 1989 Sep; 49(18):5016-22. PubMed ID: 2548707
[TBL] [Abstract][Full Text] [Related]
22. Topoisomerase I interaction with SV40 DNA in the presence and absence of camptothecin.
Jaxel C; Kohn KW; Pommier Y
Nucleic Acids Res; 1988 Dec; 16(23):11157-70. PubMed ID: 2849758
[TBL] [Abstract][Full Text] [Related]
23. Developmental activation of the capability to undergo checkpoint-induced apoptosis in the early zebrafish embryo.
Ikegami R; Hunter P; Yager TD
Dev Biol; 1999 May; 209(2):409-33. PubMed ID: 10328930
[TBL] [Abstract][Full Text] [Related]
24. Involvement of nucleic acid synthesis in cell killing mechanisms of topoisomerase poisons.
D'Arpa P; Beardmore C; Liu LF
Cancer Res; 1990 Nov; 50(21):6919-24. PubMed ID: 1698546
[TBL] [Abstract][Full Text] [Related]
25. Diverse effects of camptothecin, an inhibitor of topoisomerase I, on the cell cycle of lymphocytic (L1210, MOLT-4) and myelogenous (HL-60, KG1) leukemic cells.
Del Bino G; Skierski JS; Darzynkiewicz Z
Cancer Res; 1990 Sep; 50(18):5746-50. PubMed ID: 2168279
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of human neurotropic virus (JCV) DNA replication in glial cells by camptothecin.
Kerr DA; Chang CF; Gordon J; Bjornsti MA; Khalili K
Virology; 1993 Oct; 196(2):612-8. PubMed ID: 8396804
[TBL] [Abstract][Full Text] [Related]
27. Importance of replication fork progression for the induction of chromosome damage and SCE by inhibitors of DNA topoisomerases.
Cortés F; Piñero J; Ortiz T
Mutat Res; 1993 Oct; 303(2):71-6. PubMed ID: 7692280
[TBL] [Abstract][Full Text] [Related]
28. Involvement of intracellular ATP in cytotoxicity of topoisomerase II-targetting antitumor drugs.
Kupfer G; Bodley AL; Liu LF
NCI Monogr; 1987; (4):37-40. PubMed ID: 2819729
[TBL] [Abstract][Full Text] [Related]
29. Discrepancy between the initial DNA damage and cell survival after camptothecin treatment in two murine lymphoma L5178Y sublines.
Gradzka I; Szumiel I
Cell Biochem Funct; 1996 Sep; 14(3):163-71. PubMed ID: 8888569
[TBL] [Abstract][Full Text] [Related]
30. Caspase inhibition in camptothecin-treated U-937 cells is coupled with a shift from apoptosis to transient G1 arrest followed by necrotic cell death.
Sané AT; Bertrand R
Cancer Res; 1999 Aug; 59(15):3565-9. PubMed ID: 10446962
[TBL] [Abstract][Full Text] [Related]
31. Differential GADD45, p21CIP1/WAF1, MCL-1 and topoisomerase II gene induction and secondary DNA fragmentation after camptothecin-induced DNA damage in two mutant p53 human colon cancer cell lines.
Goldwasser F; Bae I; Fornace AJ; Pommier Y
Oncol Res; 1996; 8(7-8):317-23. PubMed ID: 8938795
[TBL] [Abstract][Full Text] [Related]
32. Characterization of a camptothecin-resistant human DNA topoisomerase I in an in vitro system for Simian virus 40 DNA replication.
Ishimi Y; Nishizawa M; Andoh T
Eur J Biochem; 1991 Dec; 202(3):835-9. PubMed ID: 1662615
[TBL] [Abstract][Full Text] [Related]
33. Effects of VM26, a specific inhibitor of type II DNA topoisomerase, on SV40 chromatin replication in vitro.
Richter A; Strausfeld U
Nucleic Acids Res; 1988 Nov; 16(21):10119-29. PubMed ID: 2848217
[TBL] [Abstract][Full Text] [Related]
34. DNA topoisomerase inhibitors block erythropoiesis and delay hemoglobinization in vitro.
Dainiak N; Kreczko S; Hanspal M; Strauss PR
J Cell Physiol; 1989 Jan; 138(1):87-96. PubMed ID: 2536038
[TBL] [Abstract][Full Text] [Related]
35. Effect of inhibition of DNA synthesis on recovery of X-irradiated L5178Y-S cells. I. Aphidicolin.
Kapiszewska M; Lange CS
Neoplasma; 1989; 36(5):557-64. PubMed ID: 2510032
[TBL] [Abstract][Full Text] [Related]
36. Camptothecin induces protein-linked DNA breaks via mammalian DNA topoisomerase I.
Hsiang YH; Hertzberg R; Hecht S; Liu LF
J Biol Chem; 1985 Nov; 260(27):14873-8. PubMed ID: 2997227
[TBL] [Abstract][Full Text] [Related]
37. Patterns of strongly protein-associated simian virus 40 DNA replication intermediates resulting from exposures to specific topoisomerase poisons.
Shin CG; Snapka RM
Biochemistry; 1990 Dec; 29(49):10934-9. PubMed ID: 2176889
[TBL] [Abstract][Full Text] [Related]
38. Initiation of simian virus 40 DNA replication in vitro: aphidicolin causes accumulation of early-replicating intermediates and allows determination of the initial direction of DNA synthesis.
Decker RS; Yamaguchi M; Possenti R; DePamphilis ML
Mol Cell Biol; 1986 Nov; 6(11):3815-25. PubMed ID: 3025613
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of DNA synthesis by aphidicolin induces supercoiling in simian virus 40 replicative intermediates.
Dröge P; Sogo JM; Stahl H
EMBO J; 1985 Dec; 4(12):3241-6. PubMed ID: 3004946
[TBL] [Abstract][Full Text] [Related]
40. Quinobenoxazines: a class of novel antitumor quinolones and potent mammalian DNA topoisomerase II catalytic inhibitors.
Permana PA; Snapka RM; Shen LL; Chu DT; Clement JJ; Plattner JJ
Biochemistry; 1994 Sep; 33(37):11333-9. PubMed ID: 7727384
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
